Trxade Group Inc (NASDAQ:MEDS) — Market Cap & Net Worth
Market Cap & Net Worth: Trxade Group Inc (MEDS)
Trxade Group Inc (NASDAQ:MEDS) has a market capitalization of $2.40 Million ($2.40 Million) as of August 24, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29863 globally and #6059 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Trxade Group Inc's stock price $1.37 by its total outstanding shares 1750060 (1.75 Million). See Trxade Group Inc balance sheet quality to understand what proportion of total assets are financed by equity.
Trxade Group Inc Market Cap History: 2015 to 2026
Trxade Group Inc's market capitalization history from 2015 to 2026. Data shows change from $78.31 Million to $2.40 Million (-26.85% CAGR). Also see MEDS current and non-current assets for a full breakdown of the balance sheet.
Index Memberships
Trxade Group Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$41.42 Trillion | 0.00% | #2784 of 3165 |
Weight: Trxade Group Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Trxade Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Trxade Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check MEDS share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.50x
Trxade Group Inc's market cap is 0.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $78.31 Million | $4.99 Million | -$1.12 Million | 15.69x | N/A |
| 2016 | $32.75 Million | $2.48 Million | -$2.76 Million | 13.20x | N/A |
| 2017 | $32.04 Million | $2.93 Million | $288.98K | 10.93x | 110.86x |
| 2018 | $21.36 Million | $3.83 Million | $9.04K | 5.57x | 2363.08x |
| 2019 | $78.31 Million | $7.44 Million | -$409.73K | 10.53x | N/A |
| 2020 | $62.77 Million | $17.12 Million | -$2.57 Million | 3.67x | N/A |
| 2021 | $28.00 Million | $9.89 Million | -$4.11 Million | 2.83x | N/A |
| 2022 | $4.78 Million | $11.45 Million | -$4.31 Million | 0.42x | N/A |
| 2023 | $4.11 Million | $8.27 Million | -$17.84 Million | 0.50x | N/A |
Competitor Companies of MEDS by Market Capitalization
Companies near Trxade Group Inc in the global market cap rankings as of August 24, 2026. Also see cash flow conversion of Trxade Group Inc for how efficiently the company converts equity into cash flow.
Key companies related to Trxade Group Inc by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1727 globally with a market cap of $14.12 Billion USD ( €12.08 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2211 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2570 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3102 globally with a market cap of $6.32 Billion USD ( R$32.23 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1727 | JD HEALTH INTL LTD | F:8ZN | $14.12 Billion | €4.17 |
| #2211 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2570 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3102 | Raia Drogasil S.A | SA:RADL3 | $6.32 Billion | R$18.43 |
Trxade Group Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Trxade Group Inc's market cap moved from $78.31 Million to $ 2.40 Million, with a yearly change of -26.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.40 Million | -81.83% |
| 2024 | $13.20 Million | +221.03% |
| 2023 | $4.11 Million | -13.95% |
| 2022 | $4.78 Million | -82.94% |
| 2021 | $28.00 Million | -55.39% |
| 2020 | $62.77 Million | -19.85% |
| 2019 | $78.31 Million | +266.67% |
| 2018 | $21.36 Million | -33.33% |
| 2017 | $32.04 Million | -2.17% |
| 2016 | $32.75 Million | -58.18% |
| 2015 | $78.31 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 24th, 2026 the market cap of Trxade Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.40 Million USD |
| MoneyControl | $2.40 Million USD |
| MarketWatch | $2.40 Million USD |
| marketcap.company | $2.40 Million USD |
| Reuters | $2.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Trxade Group Inc
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.